Uso da cannabis medicinal no tratamento da dermatite atópica canina

Detalhes bibliográficos
Ano de defesa: 2023
Autor(a) principal: Mariga, Carollina
Orientador(a): Não Informado pela instituição
Banca de defesa: Não Informado pela instituição
Tipo de documento: Dissertação
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Universidade Federal de Santa Maria
Brasil
Medicina Veterinária
UFSM
Programa de Pós-Graduação em Medicina Veterinária
Centro de Ciências Rurais
Programa de Pós-Graduação: Não Informado pela instituição
Departamento: Não Informado pela instituição
País: Não Informado pela instituição
Palavras-chave em Português:
DAC
CBD
CAD
Link de acesso: http://repositorio.ufsm.br/handle/1/28500
Resumo: Dermatological consultations represent 40% of the routine in the small animal medical clinic, with canine atopic dermatitis (CAD) reported between 3 to 15% of the canine population. The role of the endocannabinoid system in the skin does not only reveal its direct action on homeostasis and its deregulation contributing to dermatopathies, but the detail of its presence in specialized skin cells reveals a delicate and complex therapeutic potential. Due to the difficulties and the growing scientific evidence of the therapeutic benefits of cannabis, this work aimed to evaluate the anti-inflammatory effect of cannabis oil in the treatment of this disease. For this, canines diagnosed with CAD were divided into two groups: the treated group [using full spectrum high cannabidiol (CBD) cannabis oil] and the control group (treated with olive oil). The evaluation methods for the effectiveness of the therapy were based on the degree of pruritus, dermatological evaluation through CADESI-4, measurement of interleukins 6, 10 and 31, oxidative stress and histopathological evaluation of the skin with mast cell count. Despite the theoretical basis, in this work no significant results were obtained between the compared treatments. Thus, it is concluded that the full spectrum high CBD cannabis oil presents a promising approach in the multi-target treatment of CAD, requiring further research to study its therapeutic value in this canine disease.